Literature DB >> 21226472

Insight into technetium amidoxime complex: oxo technetium(V) complex of N-substituted benzamidoxime as new basic structure for molecular imaging.

Khajadpai Thipyapong1, Tomoya Uehara, Yuji Tooyama, Henrik Braband, Roger Alberto, Yasushi Arano.   

Abstract

In search of benzamidoxime (BHam) derivatives that provide a single (99m)Tc-labeled compound of high in vivo stability, we synthesized three N-alkyl compounds of benzamidoxime (BHam) ligand. They provided a single (99m)Tc-labeled compound by ligand exchange reaction of (99m)Tc-glucoheptonate in high radiochemical yields (over 95% at MBHam concentration of 1 × 10(-5) M). (99m)Tc-N-methyl benzamidoxime ((99m)Tc-MBHam) showed higher stability than the parental (99m)Tc-BHam. The complex of this compound with (99g)TcO(3+) ion was prepared, isolated, and characterized by FT-IR and NMR spectra as well as X-ray diffraction. (99g)Tc-MBHam crystallized in an orthorhombic space group Pna2(1) with a = 13.4823(5), b = 15.5410(7), c = 7.7907(3) Å, V = 1632.39(11) Å(3), and Z = 4. The (99g)Tc complex possessed square base pyramid coordination geometry. The equatorial plane was formed by two-amine nitrogen and two-oxime oxygen atoms in trans position, while the oxo core of the technetium(V) occupied the apical position. The (99g)Tc-MBHam proved to be identical with the (99m)Tc-MBHam prepared at the no-carrier-added level by comparison of their HPLC profiles.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21226472     DOI: 10.1021/ic101714q

Source DB:  PubMed          Journal:  Inorg Chem        ISSN: 0020-1669            Impact factor:   5.165


  2 in total

Review 1.  Recent progress in the development of metal complexes as β-amyloid imaging probes in the brain.

Authors:  Kaihua Chen; Mengchao Cui
Journal:  Medchemcomm       Date:  2017-05-16       Impact factor: 3.597

2.  Novel Bivalent 99mTc-Complex with N-Methyl-Substituted Hydroxamamide as Probe for Imaging of Cerebral Amyloid Angiopathy.

Authors:  Shimpei Iikuni; Masahiro Ono; Hiroyuki Watanabe; Masashi Yoshimura; Hatsue Ishibashi-Ueda; Masafumi Ihara; Hideo Saji
Journal:  PLoS One       Date:  2016-09-30       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.